Microrobots controlled by external magnets can deliver drugs to hard-to-reach blood clots and speed up their dissolution by roughly 10 times, researchers at ETH Zurich concluded after preclinical trials, the website infohub.kz reports.
The team's invention creates microvortices in the bloodstream and steers clot-dissolving drugs directly toward hard-to-reach blockages in blood vessels, Live Science writes.
When a blood vessel is blocked, fluid in the branching system begins to bypass the obstructed section through neighboring pathways, which makes it difficult for conventional thrombolytic drugs to cover the last few millimeters to the target. To solve this problem, a team led by Professor of Medical Microsystems Simone Schürle created bullet-shaped microparticles inspired by bacteria that use magnetic structures to navigate in the Earth's magnetic field.
Each microrobot consists of a rigid magnetic rod based on iron oxide nanoparticles and a protective shell of hydrogel polymer that prevents the particles from sticking together.
Under the influence of a rotating magnetic field, the robots begin to tumble inside the vessel and create microvortices that direct the drug straight to the clot. The technology was first tested on a silicone model of a vessel with pig blood clots, where dissolution accelerated 10-fold.
The experiment was then repeated on live pigs with clots in the renal vessels: administering the robots and the drug together restored blood flow over a much larger area.
Earlier experiments on mice showed that the microrobots' materials break down safely in the body within a few weeks; the scientists are now preparing long-term safety trials on large animals before moving on to tests in humans.


